BioCentury
ARTICLE | Company News

Epitome, Medigene, Mitsui, Triton Pharma Inc. deal

April 25, 2011 7:00 AM UTC

MediGene granted Triton exclusive, Canadian rights to develop and commercialize Veregen sinecatechins ointment to treat genital warts. Triton will be responsible for Canadian approval of the topical formulation of polyphenols extracted from green tea leaves. MediGene is eligible for milestones of up to €2.1 million ($3 million), plus double-digit royalties. ...